Form 4: Hinge Health CFO James Budge Executes Stock Sale
Statement of Changes in Beneficial Ownership
Hinge Health CFO James Budge sold 5,907 shares of Class A Common Stock on May 26, 2026, pursuant to a Rule 10b5-1 trading plan.
Summary
- CFO James Budge sold a total of 5,907 shares of Class A Common Stock.
- The transactions occurred on May 26, 2026, at weighted average prices ranging from $53.32 to $55.22 per share.
- The sales were executed under a pre-established Rule 10b5-1 trading plan adopted on June 12, 2025.
- Following these transactions, James Budge retains beneficial ownership of 445,386 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned, automated trading program.
Positives
- The sale was conducted via a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.
Negatives
- The transaction represents a reduction in the direct equity stake held by the Chief Financial Officer.
Risks
- Insider selling can sometimes be perceived negatively by the market, potentially signaling that the executive believes the stock price has reached a near-term peak.
Future Outlook
No specific forward-looking guidance regarding company performance was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling via 10b5-1 plans is common practice for executives at publicly traded companies and generally does not reflect a change in corporate strategy or outlook.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate officers to manage personal liquidity while maintaining regulatory compliance.
Stakeholder Impact
- Shareholders should note the reduction in insider holdings, though the systematic nature of the sale suggests it is for personal financial planning rather than a reaction to company performance.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date the Rule 10b5-1 trading plan was adopted. |
| 05/26/2026 | Date of the reported stock transactions. |
| 05/27/2026 | Date the Form 4 was signed and filed. |
Keywords
Hinge Health, HNGE, Insider Trading, Form 4, CFO, Equity Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.